Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Maat Pharma SA | 2.23m | -19.72m | 104.51m | 50.00 | -- | 4.27 | -- | 46.91 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Transgene SA | 7.63m | -22.33m | 107.88m | 158.00 | -- | 6.85 | -- | 14.13 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Eurofins-Cerep SA | 44.07m | 7.64m | 111.98m | 228.00 | 14.66 | 1.73 | 11.65 | 2.54 | 1,514.43 | 1,514.43 | 8,743.94 | 12,820.37 | 0.5864 | 1.67 | 5.08 | 193,287.10 | 10.16 | 14.21 | 12.22 | 17.51 | 85.01 | 73.61 | 17.33 | 19.77 | 4.87 | -- | 0.00005 | -- | -7.47 | 11.60 | -33.72 | 14.64 | -- | -- |
| Cellectis SA | 11.34m | -73.28m | 121.12m | 235.00 | -- | 1.43 | -- | 10.68 | -1.24 | -1.05 | 0.1663 | 1.18 | 0.04 | -- | 1.41 | 48,238.90 | -27.82 | -24.08 | -42.40 | -30.69 | -- | -64.64 | -694.72 | -308.24 | -- | -- | 0.552 | -- | -64.26 | -15.57 | -20.55 | -- | -26.15 | -- |
| Ose Immunotherapeutics SA | 2.23m | -23.00m | 127.85m | 62.00 | -- | 5.50 | -- | 57.41 | -1.18 | -1.18 | 0.1166 | 1.06 | 0.0256 | -- | 3.22 | -- | -26.46 | -17.17 | -33.15 | -20.55 | -- | -- | -1,032.87 | -94.71 | -- | -97.81 | 0.6659 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Adocia SA | 2.15m | -21.16m | 128.16m | 78.00 | -- | -- | -- | 59.61 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Eurobio Scientific SA | 130.00m | 4.84m | 142.46m | 137.00 | 32.22 | 0.8675 | 7.92 | 1.10 | 0.4315 | 0.4315 | 11.59 | 16.02 | 0.4018 | 3.19 | 4.31 | 948,927.00 | 1.49 | 16.91 | 1.80 | 21.53 | 47.11 | 50.95 | 3.72 | 23.34 | 2.32 | 4.03 | 0.3666 | 0.00 | -14.81 | 20.80 | -80.61 | -- | 20.02 | -- |
| Inventiva SA | 17.48m | -110.43m | 152.45m | 112.00 | -- | -- | -- | 8.72 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Innate Pharma SA | 51.90m | -7.57m | 161.29m | 179.00 | -- | 3.10 | -- | 3.11 | -0.0939 | -0.0939 | 0.6451 | 0.642 | 0.2648 | -- | 5.67 | 289,949.70 | -3.86 | -8.83 | -4.87 | -12.11 | 94.50 | 93.17 | -14.59 | -55.55 | -- | -- | 0.6408 | -- | 4.68 | -8.27 | 86.94 | -- | 10.50 | -- |
| Genfit SA | 38.18m | -28.89m | 183.74m | 159.00 | -- | 2.70 | -- | 4.81 | -0.5814 | -0.5814 | 0.7681 | 1.36 | 0.1961 | 542.00 | 3.52 | 240,100.60 | -14.84 | -12.57 | -18.55 | -15.30 | 94.32 | 94.96 | -75.69 | -76.23 | 2.94 | -7.78 | 0.5080 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
Data as of Jun 18 2024. Currency figures normalised to OSE Immunotherapeutics SA's reporting currency: Euro EUR
2.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mandarine Gestion SAas of 29 Feb 2024 | 230.00k | 1.06% |
| Saint Olive Gestion SNCas of 29 Dec 2023 | 120.00k | 0.55% |
| La Fran�aise Asset Management SASas of 29 Feb 2024 | 110.00k | 0.51% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 30.48k | 0.14% |
| Alphajet Fair Investors SASas of 18 Jun 2024 | 13.00k | 0.06% |
| Chaussier Gestion SAas of 28 Mar 2024 | 12.00k | 0.06% |
| Gestys SAas of 26 Jan 2024 | 3.00k | 0.01% |
More ▼
Data from 23 Feb 2024 - 18 Jun 2024Source: FactSet Research Systems Inc.
